Martina Kolackova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martina Kolackova has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Jan Krejsek
Department of Clinical Immunology and Allergology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic
5 shared publications - Tereza Svadlakova
Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic
5 shared publications - Andrea Malkova
Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
4 shared publications - Eva Jozifkova
Department of Biology, Faculty of Science, Jan Evangelista Purkyně University in Ústí nad Labem , Ústí nad Labem , 400 96
4 shared publications - Radka Vankova
Institute of Clinical Immunology and Allergology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
4 shared publications - Zdenek Fiala
Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic
3 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11544
Pathological Mechanisms in Sjögren’s Disease Likely Involve the ADP-Ribosyl Cyclase Family Members: CD38 and CD157
Peripheral blood serves both as a source of effector immune cells that migrate to exocrine glands and as a reflection of the immunological changes occurring in patients with Sjögren’s disease (SjD). These changes may be linked to the clinical state of these patients. We analyzed total cell counts in the peripheral blood, as well as frequencies of individual leukocyte subpopulations, membrane expression levels of CD38 and CD157, and serum concentrations of soluble sCD38 and sCD157 in SjD patients (n = 40) and age-matched healthy controls (n = 20). Hierarchical clustering based on the cell count of leukocyte subpopulations was employed to identify distinct patient subgroups. Associations between these clusters and clinical parameters were subsequently evaluated. Key findings included a reduction in lymphocyte counts and their subpopulations, alongside increased CD38 expression on CD38+ B cells (p = 0.047) and, unexpectedly, on monocytes (p = 0.014) when comparing patients and controls. The involvement of innate immunity was further supported by the differential expression of CD157 across patient samples. Patients with low cell counts exhibited reduced CD157 expression on monocytes and granulocytes (p < 0.02), tested positive for anti-Ro antibodies, and reported severe fatigue. Our findings suggest that innate immune cells, such as monocytes and granulocytes in peripheral blood, are also likely to contribute to the manifestation and progression of SjD. The differential expression of CD157 may reflect distinct immunopathological states and warrants further investigation, as its precise role in exocrine gland involvement and extra-glandular manifestations lies beyond the scope of this study.
- 28 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11544
Open AccessPathological Mechanisms in Sjögren’s Disease Likely Involve the ADP-Ribosyl Cyclase Family Members: CD38 and CD157
Peripheral blood serves both as a source of effector immune cells that migrate to exocrine glands and as a reflection of the immunological changes occurring in patients with Sjögren’s disease (SjD). These changes may be linked to the clinical state of these patients. We analyzed total cell counts in the peripheral blood, as well as frequencies of individual leukocyte subpopulations, membrane expression levels of CD38 and CD157, and serum concentrations of soluble sCD38 and sCD157 in SjD patients (n = 40) and age-matched healthy controls (n = 20). Hierarchical clustering based on the cell count of leukocyte subpopulations was employed to identify distinct patient subgroups. Associations between these clusters and clinical parameters were subsequently evaluated. Key findings included a reduction in lymphocyte counts and their subpopulations, alongside increased CD38 expression on CD38+ B cells (p = 0.047) and, unexpectedly, on monocytes (p = 0.014) when comparing patients and controls. The involvement of innate immunity was further supported by the differential expression of CD157 across patient samples. Patients with low cell counts exhibited reduced CD157 expression on monocytes and granulocytes (p < 0.02), tested positive for anti-Ro antibodies, and reported severe fatigue. Our findings suggest that innate immune cells, such as monocytes and granulocytes in peripheral blood, are also likely to contribute to the manifestation and progression of SjD. The differential expression of CD157 may reflect distinct immunopathological states and warrants further investigation, as its precise role in exocrine gland involvement and extra-glandular manifestations lies beyond the scope of this study.
- 17 January 2024
- Published by Taylor & Francis in Deviant Behavior
- Vol. 45 (10) , 1439-1452
Exploring the Evolutionary-Biological Basis of Mating Strategies in Submissive Women: A Comparative Study in Three Subgroups of BDSM Sex Practitioners
- 17 January 2024
- Published by Taylor & Francis in Deviant Behavior
- Vol. 45 (10) , 1439-1452
Exploring the Evolutionary-Biological Basis of Mating Strategies in Submissive Women: A Comparative Study in Three Subgroups of BDSM Sex Practitioners
- Open Access
- 23 June 2023
- Published by Springer Nature in BMC Immunology
- Vol. 24 (1) , 1-15
Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjögren’s syndrome
Background: Patients with Sjögren’s syndrome, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) are among the dysregulated proteins. Methods: We studied Fas and FasL on IL-2Rα+ cells and in serum of patients with Sjögren’s syndrome (n = 16) and healthy individuals (n = 16); both from same ethnic and geographical background. We used flow cytometry and enzyme-linked immunosorbent for this purpose. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients’ T and B cells while Fas was increased in patients’ monocytes, T and B cells. No signs of increased apoptosis were found. sFas and sFasL in patients’ serum were increased, although the increase in sFasL was not significant. We suspect an effect of non-steroidal anti-inflammatory therapy on B cells, explaining the decrease of the percentage Fas+ B cells found within our samples. In healthy individuals, there was a noticeable pattern in the expression of FasL which mutually correlated to populations of mononuclear cells; this correlation was absent in the patients with Sjögren’s syndrome. Conclusions: Mononuclear cells expressing IL-2Rα+ had upregulated Fas in Sjögren’s syndrome. However, the rate of apoptosis based on Annexin V staining and the Bcl-2/Bax expression was not observed in mononuclear cells. We suspect a functional role of abnormal levels of Fas and FasL which has not been cleared yet.
- 23 June 2023
- Published by Springer Nature in BMC Immunology
- Vol. 24 (1) , 1-15
Open AccessUnsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjögren’s syndrome
Background: Patients with Sjögren’s syndrome, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) are among the dysregulated proteins. Methods: We studied Fas and FasL on IL-2Rα+ cells and in serum of patients with Sjögren’s syndrome (n = 16) and healthy individuals (n = 16); both from same ethnic and geographical background. We used flow cytometry and enzyme-linked immunosorbent for this purpose. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients’ T and B cells while Fas was increased in patients’ monocytes, T and B cells. No signs of increased apoptosis were found. sFas and sFasL in patients’ serum were increased, although the increase in sFasL was not significant. We suspect an effect of non-steroidal anti-inflammatory therapy on B cells, explaining the decrease of the percentage Fas+ B cells found within our samples. In healthy individuals, there was a noticeable pattern in the expression of FasL which mutually correlated to populations of mononuclear cells; this correlation was absent in the patients with Sjögren’s syndrome. Conclusions: Mononuclear cells expressing IL-2Rα+ had upregulated Fas in Sjögren’s syndrome. However, the rate of apoptosis based on Annexin V staining and the Bcl-2/Bax expression was not observed in mononuclear cells. We suspect a functional role of abnormal levels of Fas and FasL which has not been cleared yet.
- Open Access
- 10 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (16) , 8889
Immunotoxicity of Carbon-Based Nanomaterials, Starring Phagocytes
In the field of science, technology and medicine, carbon-based nanomaterials and nanoparticles (CNMs) are becoming attractive nanomaterials that are increasingly used. However, it is important to acknowledge the risk of nanotoxicity that comes with the widespread use of CNMs. CNMs can enter the body via inhalation, ingestion, intravenously or by any other route, spread through the bloodstream and penetrate tissues where (in both compartments) they interact with components of the immune system. Like invading pathogens, CNMs can be recognized by large numbers of receptors that are present on the surface of innate immune cells, notably monocytes and macrophages. Depending on the physicochemical properties of CNMs, i.e., shape, size, or adsorbed contamination, phagocytes try to engulf and process CNMs, which might induce pro/anti-inflammatory response or lead to modulation and disruption of basic immune activity. This review focuses on existing data on the immunotoxic potential of CNMs, particularly in professional phagocytes, as they play a central role in processing and eliminating foreign particles. The results of immunotoxic studies are also described in the context of the entry routes, impacts of contamination and means of possible elimination. Mechanisms of proinflammatory effect depending on endocytosis and intracellular distribution of CNMs are highlighted as well.
- 10 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (16) , 8889
Open AccessImmunotoxicity of Carbon-Based Nanomaterials, Starring Phagocytes
In the field of science, technology and medicine, carbon-based nanomaterials and nanoparticles (CNMs) are becoming attractive nanomaterials that are increasingly used. However, it is important to acknowledge the risk of nanotoxicity that comes with the widespread use of CNMs. CNMs can enter the body via inhalation, ingestion, intravenously or by any other route, spread through the bloodstream and penetrate tissues where (in both compartments) they interact with components of the immune system. Like invading pathogens, CNMs can be recognized by large numbers of receptors that are present on the surface of innate immune cells, notably monocytes and macrophages. Depending on the physicochemical properties of CNMs, i.e., shape, size, or adsorbed contamination, phagocytes try to engulf and process CNMs, which might induce pro/anti-inflammatory response or lead to modulation and disruption of basic immune activity. This review focuses on existing data on the immunotoxic potential of CNMs, particularly in professional phagocytes, as they play a central role in processing and eliminating foreign particles. The results of immunotoxic studies are also described in the context of the entry routes, impacts of contamination and means of possible elimination. Mechanisms of proinflammatory effect depending on endocytosis and intracellular distribution of CNMs are highlighted as well.
- Open Access
- 7 June 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (1) , 465-471
Lipid emulsions prevent postoperative abdominal adhesions
- 7 June 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (1) , 465-471
Open AccessLipid emulsions prevent postoperative abdominal adhesions
- Open Access
- 15 February 2022
- Published by Springer Nature in Research Square
New aspects of the role of Fas receptor and Fas Ligand in patients with Sjögren’s syndrome
Background: Sjögren’s syndrome patients, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) belong among dysregulated proteins. Although they have been long studied, there are still several unknown aspects of biological importance of Fas and FasL. Methods: In patients with Sjögren’s syndrome and age-matched healthy individuals, we studied Fas and FasL on IL-2Rα+ cells and in serum using flow cytometry and enzyme-linked immunosorbent assay, respectively. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients’ T and B cells and serum while Fas was increased in patients’ monocytes, T and B cells. No signs of increased apoptosis were found. We suspect an effect of non-steroidal anti-inflammatory therapy on the percentage of Fas+ B cells which decreased with the therapy in our patients. In the healthy individuals, there was a noticeable pattern in the expression of Fas which was mutually correlated between populations of mononuclear cells; this correlation was absent in the patients with Sjögren’s syndrome. Conclusions: The increased expression of Fas in IL-2Rα+ lymphocytes does not increase the apoptosis of lymphocytes. These lymphocytes increase the expression of FasL and may induce apoptosis in other cells. The lack of correlation for the expression of FasL in Sjögren’s syndrome patients may suggest a loss of regulation.
- 15 February 2022
- Published by Springer Nature in Research Square
Open AccessNew aspects of the role of Fas receptor and Fas Ligand in patients with Sjögren’s syndrome
Background: Sjögren’s syndrome patients, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) belong among dysregulated proteins. Although they have been long studied, there are still several unknown aspects of biological importance of Fas and FasL. Methods: In patients with Sjögren’s syndrome and age-matched healthy individuals, we studied Fas and FasL on IL-2Rα+ cells and in serum using flow cytometry and enzyme-linked immunosorbent assay, respectively. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients’ T and B cells and serum while Fas was increased in patients’ monocytes, T and B cells. No signs of increased apoptosis were found. We suspect an effect of non-steroidal anti-inflammatory therapy on the percentage of Fas+ B cells which decreased with the therapy in our patients. In the healthy individuals, there was a noticeable pattern in the expression of Fas which was mutually correlated between populations of mononuclear cells; this correlation was absent in the patients with Sjögren’s syndrome. Conclusions: The increased expression of Fas in IL-2Rα+ lymphocytes does not increase the apoptosis of lymphocytes. These lymphocytes increase the expression of FasL and may induce apoptosis in other cells. The lack of correlation for the expression of FasL in Sjögren’s syndrome patients may suggest a loss of regulation.
- Open Access
- 27 September 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (10) , 2510
Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards Various Bacteria and Modulate Their Differentiation into Macrophages
The evaluation of carbon-based nanomaterials’ (C-BNMs’) interactions with the immune system, notably their ability to cause inflammation, is a critical step in C-BNM health risk assessment. Particular attention should be given to those C-BNMs that do not cause direct cytotoxicity or inflammation on their own. However, the intracellular presence of these non-biodegradable nanomaterials could dysregulate additional cell functions. This is even more crucial in the case of phagocytes, which are the main mediators of defensive inflammation towards pathogens. Hence, our study was focused on multi-walled carbon nanotubes (MWCNTs) and two different types of graphene platelets (GPs) and whether their intracellular presence modulates a proinflammatory response from human primary monocytes towards common pathogens. Firstly, we confirmed that all tested C-BNMs caused neither direct cytotoxicity nor the release of tumour necrosis factor α (TNF-α), interleukin (IL)-6 or IL-10. However, such pre-exposed monocytes showed increased responsiveness to additional bacterial stimuli. In response to several types of bacteria, monocytes pre-treated with GP1 produced a significantly higher quantity of TNF-α, IL-6 and IL-10. Monocytes pre-treated with MWCNTs produced increased levels of IL-10. All the tested C-BNMs enhanced monocyte phagocytosis and accelerated their differentiation towards macrophages. This study confirms the immunomodulatory potential of C-BNMs.
- 27 September 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (10) , 2510
Open AccessCarbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards Various Bacteria and Modulate Their Differentiation into Macrophages
The evaluation of carbon-based nanomaterials’ (C-BNMs’) interactions with the immune system, notably their ability to cause inflammation, is a critical step in C-BNM health risk assessment. Particular attention should be given to those C-BNMs that do not cause direct cytotoxicity or inflammation on their own. However, the intracellular presence of these non-biodegradable nanomaterials could dysregulate additional cell functions. This is even more crucial in the case of phagocytes, which are the main mediators of defensive inflammation towards pathogens. Hence, our study was focused on multi-walled carbon nanotubes (MWCNTs) and two different types of graphene platelets (GPs) and whether their intracellular presence modulates a proinflammatory response from human primary monocytes towards common pathogens. Firstly, we confirmed that all tested C-BNMs caused neither direct cytotoxicity nor the release of tumour necrosis factor α (TNF-α), interleukin (IL)-6 or IL-10. However, such pre-exposed monocytes showed increased responsiveness to additional bacterial stimuli. In response to several types of bacteria, monocytes pre-treated with GP1 produced a significantly higher quantity of TNF-α, IL-6 and IL-10. Monocytes pre-treated with MWCNTs produced increased levels of IL-10. All the tested C-BNMs enhanced monocyte phagocytosis and accelerated their differentiation towards macrophages. This study confirms the immunomodulatory potential of C-BNMs.
- Open Access
- 27 August 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (9) , 2210
In Vitro Assessment of the Genotoxic Potential of Pristine Graphene Platelets
(1) Background: Graphene is a two-dimensional atomic structure with a wide range of uses, including for biomedical applications. However, knowledge of its hazards is still limited. This work brings new cytotoxic, cytostatic, genotoxic and immunotoxic data concerning the in vitro exposure of human cell line to two types of graphene platelets (GP). It also contributes to the formation of general conclusions about the health risks of GP exposure. (2) Methods: In vitro exposure of a THP-1 cell line to three concentrations of two GP over 40 h. The cytotoxic potential was assessed by the measurement of LDH and glutathione (ROS) and by a trypan blue exclusion assay (TBEA); the cytostatic and genotoxic potential were assessed by the cytokinesis-block micronucleus (CBMN) test; and the immunotoxic potential was assessed by the measurement of IL-6, IL-10 and TNF-α. (3) Results: We found a significant dose-dependent increase in DNA damage (CBMN). The lowest observed genotoxic effect levels (LOGEL) were 5 µg/mL (GP1) and 30 µg/mL (GP2). We found no significant leaking of LDH from cells, increase in dead cells (TBEA), induction of ROS, increased levels of cytostasis, or changes in IL-6, IL-10 and TNF-α levels. (4) Conclusions: The genotoxicity increased during the short-term in vitro exposure of THP-1 to two GP. No increase in cytotoxicity, immunotoxicity, or cytostasis was observed.
- 27 August 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (9) , 2210
Open AccessIn Vitro Assessment of the Genotoxic Potential of Pristine Graphene Platelets
(1) Background: Graphene is a two-dimensional atomic structure with a wide range of uses, including for biomedical applications. However, knowledge of its hazards is still limited. This work brings new cytotoxic, cytostatic, genotoxic and immunotoxic data concerning the in vitro exposure of human cell line to two types of graphene platelets (GP). It also contributes to the formation of general conclusions about the health risks of GP exposure. (2) Methods: In vitro exposure of a THP-1 cell line to three concentrations of two GP over 40 h. The cytotoxic potential was assessed by the measurement of LDH and glutathione (ROS) and by a trypan blue exclusion assay (TBEA); the cytostatic and genotoxic potential were assessed by the cytokinesis-block micronucleus (CBMN) test; and the immunotoxic potential was assessed by the measurement of IL-6, IL-10 and TNF-α. (3) Results: We found a significant dose-dependent increase in DNA damage (CBMN). The lowest observed genotoxic effect levels (LOGEL) were 5 µg/mL (GP1) and 30 µg/mL (GP2). We found no significant leaking of LDH from cells, increase in dead cells (TBEA), induction of ROS, increased levels of cytostasis, or changes in IL-6, IL-10 and TNF-α levels. (4) Conclusions: The genotoxicity increased during the short-term in vitro exposure of THP-1 to two GP. No increase in cytotoxicity, immunotoxicity, or cytostasis was observed.
- Open Access
- 8 December 2020
- Published by Masaryk University Press in Anthropologia integra
- Vol. 11 (2) , 7-16
Dominanční hierarchie
Dominanční hierarchie se vyvinula jako adaptace sociálně žijících živočichů na podmínky prostředí. Postavení v dominanční hierarchii výrazně ovlivňuje život a chování člověka i v dnešních moderních evropských a amerických společnostech. Zde 1) stručně vysvětlíme principy a evoluční pozadí dominanční hierarchie z úhlu pohledu behaviorálních věd, 2) popíšeme rysy dominanční hierarchie u člověka, a 3) uvedeme příklady toho, co určuje hierarchické postavení jedince u člověka, jak toto postavení ovlivňuje život jedince a jak se projevuje v chování.Struktura dominanční hierarchie, ustavení hierarchického postavení (rank) a omezení daná tímto postavením jsou předvídatelná. Postavení ovlivňuje život jedince v mnoha směrech (reprodukce, komunikace, zdraví, tok informací, vzorce chování). Pokud chceme plně porozumět chování člověka, jeho rozhodnutím a pocitům, musíme brát v úvahu existence dominanční hierarchie mezi jedinci a mezi skupinami jedinců.
- 8 December 2020
- Published by Masaryk University Press in Anthropologia integra
- Vol. 11 (2) , 7-16
Open AccessDominanční hierarchie
Dominanční hierarchie se vyvinula jako adaptace sociálně žijících živočichů na podmínky prostředí. Postavení v dominanční hierarchii výrazně ovlivňuje život a chování člověka i v dnešních moderních evropských a amerických společnostech. Zde 1) stručně vysvětlíme principy a evoluční pozadí dominanční hierarchie z úhlu pohledu behaviorálních věd, 2) popíšeme rysy dominanční hierarchie u člověka, a 3) uvedeme příklady toho, co určuje hierarchické postavení jedince u člověka, jak toto postavení ovlivňuje život jedince a jak se projevuje v chování.Struktura dominanční hierarchie, ustavení hierarchického postavení (rank) a omezení daná tímto postavením jsou předvídatelná. Postavení ovlivňuje život jedince v mnoha směrech (reprodukce, komunikace, zdraví, tok informací, vzorce chování). Pokud chceme plně porozumět chování člověka, jeho rozhodnutím a pocitům, musíme brát v úvahu existence dominanční hierarchie mezi jedinci a mezi skupinami jedinců.
- Open Access
- 27 February 2020
- Published by MDPI AG in Nanomaterials
- Vol. 10 (3) , 418
Proinflammatory Effect of Carbon-Based Nanomaterials: In Vitro Study on Stimulation of Inflammasome NLRP3 via Destabilisation of Lysosomes
Carbon-based nanomaterials (C-BNM) have recently attracted an increased attention as the materials with potential applications in industry and medicine. Bioresistance and proinflammatory potential of C-BNM is the main obstacle for their medicinal application which was documented in vivo and in vitro. However, there are still limited data especially on graphene derivatives such as graphene platelets (GP). In this work, we compared multi-walled carbon nanotubes (MWCNT) and two different types of pristine GP in their potential to activate inflammasome NLRP3 (The nod-like receptor family pyrin domain containing 3) in vitro. Our study is focused on exposure of THP-1/THP1-null cells and peripheral blood monocytes to C-BNM as representative models of canonical and alternative pathways, respectively. Although all nanomaterials were extensively accumulated in the cytoplasm, increasing doses of all C-BNM did not lead to cell death. We observed direct activation of NLRP3 via destabilization of lysosomes and release of cathepsin B into cytoplasm only in the case of MWCNTs. Direct activation of NLRP3 by both GP was statistically insignificant but could be induced by synergic action with muramyl dipeptide (MDP), as a representative molecule of the family of pathogen-associated molecular patterns (PAMPs). This study demonstrates a possible proinflammatory potential of GP and MWCNT acting through NLRP3 activation.
- 27 February 2020
- Published by MDPI AG in Nanomaterials
- Vol. 10 (3) , 418
Open AccessProinflammatory Effect of Carbon-Based Nanomaterials: In Vitro Study on Stimulation of Inflammasome NLRP3 via Destabilisation of Lysosomes
Carbon-based nanomaterials (C-BNM) have recently attracted an increased attention as the materials with potential applications in industry and medicine. Bioresistance and proinflammatory potential of C-BNM is the main obstacle for their medicinal application which was documented in vivo and in vitro. However, there are still limited data especially on graphene derivatives such as graphene platelets (GP). In this work, we compared multi-walled carbon nanotubes (MWCNT) and two different types of pristine GP in their potential to activate inflammasome NLRP3 (The nod-like receptor family pyrin domain containing 3) in vitro. Our study is focused on exposure of THP-1/THP1-null cells and peripheral blood monocytes to C-BNM as representative models of canonical and alternative pathways, respectively. Although all nanomaterials were extensively accumulated in the cytoplasm, increasing doses of all C-BNM did not lead to cell death. We observed direct activation of NLRP3 via destabilization of lysosomes and release of cathepsin B into cytoplasm only in the case of MWCNTs. Direct activation of NLRP3 by both GP was statistically insignificant but could be induced by synergic action with muramyl dipeptide (MDP), as a representative molecule of the family of pathogen-associated molecular patterns (PAMPs). This study demonstrates a possible proinflammatory potential of GP and MWCNT acting through NLRP3 activation.